← back to search

Julia Furtner

Danube Private University · AT
Area of research
Genetics · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging, and Meningioma and schwannoma management.
h-index
36
citations
4,908
works
275
NIH funding
primary concept
Medicine
email

Recent publications

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib
Cancer Cell 2025cited by 36position: middledoi
RANO criteria for response assessment of brain metastases based on amino acid PET imaging
Nature Medicine 2025cited by 22position: middledoi
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0
European Journal of Nuclear Medicine and Molecular Imaging 2025cited by 15position: middledoi
Availability and use of PET in patients with brain tumours – a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
European Journal of Nuclear Medicine and Molecular Imaging 2025cited by 5position: middledoi
Radiological assessment of Sella Turcica morphology correlates with skeletal classes in an Austrian population: an observational study.
2025cited by 4position: contributordoi
Prognostic stratification of newly diagnosed IDH-mutant gliomas by [18F]fluoroethyltyrosine and [11C]methionine PET: A retrospective, bicentric cohort study.
2025cited by 2position: contributordoi
Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location.
2025cited by 1position: contributordoi
Predicting critical surgical characteristics of intracranial meningiomas on MRI-A prospective study on 100 consecutive patients.
2025cited by 0position: contributordoi
The concept, intention, and evaluation of the term treatment-refractory meningioma.
2025cited by 0position: contributordoi
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
European Journal of Nuclear Medicine and Molecular Imaging 2024cited by 56position: middledoi
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
2024cited by 38position: contributordoi
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Neuro-Oncology 2024cited by 7position: middledoi
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.
2024cited by 4position: contributordoi
Clinical application of machine-based deep learning in patients with radiologically presumed adult-type diffuse glioma grades 2 or 3.
2024cited by 2position: contributordoi
Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
ESMO Open 2023cited by 122position: middledoi
Advanced <scp>MR</scp> Techniques for Preoperative Glioma Characterization: Part 1
Journal of Magnetic Resonance Imaging 2023cited by 76position: middledoi
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups
The Lancet Oncology 2023cited by 56position: middledoi
Advanced<scp>MR</scp>Techniques for Preoperative Glioma Characterization: Part 2
Journal of Magnetic Resonance Imaging 2023cited by 54position: middledoi
Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms
Scientific Reports 2023cited by 41position: middledoi
Segmentation of glioblastomas in early post-operative multi-modal MRI with deep neural networks
Scientific Reports 2023cited by 26position: middledoi
The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups
Cancers 2023cited by 7position: middledoi
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
Journal of Clinical Oncology 2023cited by 2position: middledoi
Prognostic impact of genetic alterations and methylation classes in meningioma
Brain Pathology 2022cited by 70position: middledoi
Adult Medulloblastoma: Updates on Current Management and Future Perspectives
Cancers 2022cited by 22position: middledoi
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.
2022cited by 14position: contributordoi
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
2022cited by 8position: contributordoi
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Neuro-Oncology 2021cited by 76position: middledoi
Temporal muscle thickness as a prognostic marker in newly diagnosed glioblastoma patients: translational imaging analysis of the CENTRIC EORTC 26071-22072 and CORE trials
Zurich Open Repository and Archive (University of Zurich) 2021cited by 52position: firstdoi
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study
Neuro-Oncology Advances 2021cited by 30position: middledoi
Distributed changes of the functional connectome in patients with glioblastoma
Scientific Reports 2020cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthias Preusser · Comprehensive Cancer Center Vienna15 papers (2015–2025)Michael Weller · Center for Neurosciences15 papers (2015–2025)Émilie Le Rhun · University Hospital of Zurich9 papers (2015–2025)Martin J. van den Bent · St James's University Hospital9 papers (2019–2025)Wolfgang Wick · Heidelberger Institut für Radioonkologie8 papers (2015–2024)Georg Widhalm · Vienna General Hospital8 papers (2019–2025) · 8 papers (2022–2025)Matthias Preusser · Comprehensive Cancer Center Vienna8 papers (2019–2024)Adelheid Woehrer · Center For Biomarker Research In Medicine7 papers (2019–2025)Martin Bendszus · University Hospital and Clinics6 papers (2019–2024)Anna S. Berghoff · Universitätszahnklinik Wien6 papers (2015–2022)Thierry Gorlia · Aix-Marseille Université5 papers (2019–2024)Felix Sahm · Heidelberg (Poland)5 papers (2020–2025)Georg Widhalm · Vienna General Hospital5 papers (2018–2022)Roberta Rudà · European Institute of Oncology5 papers (2015–2023)Patrick Y. Wen · Harvard University5 papers (2018–2025)Barbara Kiesel · Comprehensive Cancer Center Vienna4 papers (2018–2020)Christine Marosi · Medical University of Vienna4 papers (2015–2022)Petter Brandal · University of Oslo3 papers (2023–2025)Nathalie L. Albert · Inserm3 papers (2024–2025)